These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 18635336)
1. Inhibition of inflammatory mediator secretion by (-)-DHMEQ in mouse bone marrow-derived macrophages. Suzuki E; Sugiyama C; Umezawa K Biomed Pharmacother; 2009 Jun; 63(5):351-8. PubMed ID: 18635336 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of macrophage activation and phagocytosis by a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin. Suzuki E; Umezawa K Biomed Pharmacother; 2006 Nov; 60(9):578-86. PubMed ID: 16978829 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1. Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of inflammatory cytokine secretion from mouse microglia cells by DHMEQ, an NF-kappaB inhibitor. Takatsuna H; Morita S; Nagatsu T; Sawada M; Umezawa K Biomed Pharmacother; 2005 Jul; 59(6):318-22. PubMed ID: 15932789 [TBL] [Abstract][Full Text] [Related]
5. Induction of histidine decarboxylase in macrophages inhibited by the novel NF-kappaB inhibitor (-)-DHMEQ. Suzuki E; Ninomiya Y; Umezawa K Biochem Biophys Res Commun; 2009 Feb; 379(2):379-83. PubMed ID: 19103154 [TBL] [Abstract][Full Text] [Related]
6. Bis-(3-hydroxyphenyl) diselenide inhibits LPS-stimulated iNOS and COX-2 expression in RAW 264.7 macrophage cells through the NF-kappaB inactivation. Shin KM; Shen L; Park SJ; Jeong JH; Lee KT J Pharm Pharmacol; 2009 Apr; 61(4):479-86. PubMed ID: 19298695 [TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation. Zhou HY; Shin EM; Guo LY; Youn UJ; Bae K; Kang SS; Zou LB; Kim YS Eur J Pharmacol; 2008 May; 586(1-3):340-9. PubMed ID: 18378223 [TBL] [Abstract][Full Text] [Related]
8. A phenolic acid phenethyl urea compound inhibits lipopolysaccharide-induced production of nitric oxide and pro-inflammatory cytokines in cell culture. Hwang JM; Yu JY; Jang YO; Kim BT; Hwang KJ; Jeon YM; Lee JC Int Immunopharmacol; 2010 Apr; 10(4):526-32. PubMed ID: 20138247 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of lipopolysaccharide-inducible nitric oxide synthase and IL-1beta through suppression of NF-kappaB activation by 3-(1'-1'-dimethyl-allyl)-6-hydroxy-7-methoxy-coumarin isolated from Ruta graveolens L. Raghav SK; Gupta B; Shrivastava A; Das HR Eur J Pharmacol; 2007 Mar; 560(1):69-80. PubMed ID: 17292351 [TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effect of allylpyrocatechol in LPS-induced macrophages is mediated by suppression of iNOS and COX-2 via the NF-kappaB pathway. Sarkar D; Saha P; Gamre S; Bhattacharjee S; Hariharan C; Ganguly S; Sen R; Mandal G; Chattopadhyay S; Majumdar S; Chatterjee M Int Immunopharmacol; 2008 Sep; 8(9):1264-71. PubMed ID: 18602073 [TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory activity of 21(alpha, beta)-methylmelianodiols, novel compounds from Poncirus trifoliata Rafinesque. Zhou HY; Shin EM; Guo LY; Zou LB; Xu GH; Lee SH; Ze KR; Kim EK; Kang SS; Kim YS Eur J Pharmacol; 2007 Oct; 572(2-3):239-48. PubMed ID: 17662711 [TBL] [Abstract][Full Text] [Related]
12. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo. Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of lipopolysaccharide-induced iNOS and COX-2 expression by dehydroevodiamine through suppression of NF-kappaB activation in RAW 264.7 macrophages. Noh EJ; Ahn KS; Shin EM; Jung SH; Kim YS Life Sci; 2006 Jul; 79(7):695-701. PubMed ID: 16554073 [TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory activities of ent-16alphaH,17-hydroxy-kauran-19-oic acid isolated from the roots of Siegesbeckia pubescens are due to the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB inactivation. Park HJ; Kim IT; Won JH; Jeong SH; Park EY; Nam JH; Choi J; Lee KT Eur J Pharmacol; 2007 Mar; 558(1-3):185-93. PubMed ID: 17207792 [TBL] [Abstract][Full Text] [Related]
15. Acacetin suppressed LPS-induced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice. Pan MH; Lai CS; Wang YJ; Ho CT Biochem Pharmacol; 2006 Nov; 72(10):1293-303. PubMed ID: 16949556 [TBL] [Abstract][Full Text] [Related]
16. Fermented guava leaf extract inhibits LPS-induced COX-2 and iNOS expression in Mouse macrophage cells by inhibition of transcription factor NF-kappaB. Choi SY; Hwang JH; Park SY; Jin YJ; Ko HC; Moon SW; Kim SJ Phytother Res; 2008 Aug; 22(8):1030-4. PubMed ID: 18618521 [TBL] [Abstract][Full Text] [Related]
17. Diarctigenin, a lignan constituent from Arctium lappa, down-regulated zymosan-induced transcription of inflammatory genes through suppression of DNA binding ability of nuclear factor-kappaB in macrophages. Kim BH; Hong SS; Kwon SW; Lee HY; Sung H; Lee IJ; Hwang BY; Song S; Lee CK; Chung D; Ahn B; Nam SY; Han SB; Kim Y J Pharmacol Exp Ther; 2008 Nov; 327(2):393-401. PubMed ID: 18694995 [TBL] [Abstract][Full Text] [Related]
18. Effect of 5-O-Methylhirsutanonol on nuclear factor-kappaB-dependent production of NO and expression of iNOS in lipopolysaccharide-induced RAW264.7 cells. Han JM; Lee WS; Kim JR; Son J; Kwon OH; Lee HJ; Lee JJ; Jeong TS J Agric Food Chem; 2008 Jan; 56(1):92-8. PubMed ID: 18069795 [TBL] [Abstract][Full Text] [Related]
19. 4-O-Methylgallic acid suppresses inflammation-associated gene expression by inhibition of redox-based NF-kappaB activation. Na HJ; Lee G; Oh HY; Jeon KS; Kwon HJ; Ha KS; Lee H; Kwon YG; Kim YM Int Immunopharmacol; 2006 Oct; 6(10):1597-608. PubMed ID: 16919832 [TBL] [Abstract][Full Text] [Related]
20. Nafamostat mesilate suppresses NF-kappaB activation and NO overproduction in LPS-treated macrophages. Noguchi S; Nakatsuka M; Konishi H; Kamada Y; Chekir C; Kudo T Int Immunopharmacol; 2003 Sep; 3(9):1335-44. PubMed ID: 12890431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]